LDCFX | LDLKX | LDCFX / LDLKX | |
Total Expense Ratio | 0.50 | 0.63 | 79% |
Annual Report Gross Expense Ratio | 0.62 | 0.63 | 98% |
Fund Existence | 8 years | 10 years | - |
Gain YTD | 3.406 | 3.785 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 630M | 42.8B | 1% |
Annual Yield % from dividends | 4.69 | 4.99 | 94% |
Returns for 1 year | 5.04 | 5.40 | 93% |
Returns for 3 years | 14.56 | 13.76 | 106% |
Returns for 5 years | 12.14 | 12.62 | 96% |
Returns for 10 years | N/A | 28.19 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
STEW | 18.09 | 0.09 | +0.50% |
SRH Total Return Fund | |||
IBTO | 24.42 | 0.06 | +0.25% |
iShares iBonds Dec 2033 Term Trsy ETF | |||
KLIP | 32.80 | 0.02 | +0.05% |
KraneShares KWEB Covered Call Strat ETF | |||
HELX | 29.28 | -0.20 | -0.69% |
Franklin Genomic Advancements ETF | |||
EUAD | 41.57 | -1.47 | -3.42% |
Select STOXX Europe Aerospace & Defense ETF |